While, extravascular RBC destruction by the reticuloendothelial system predominately occurs in the spleen and liver, RBCs have been shown to infiltrate the vascular endothelium in early atherosclerotic plaques 64
The reduction of cardiovascular disease does not decrease medical claims to the point where it is more financially beneficial to include the GLP-1s on the drug formularies because the claims resulting from the medication alone are higher than the claims related to cardiovascular treatments
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients With and Without Diabetes (LIVE)-A Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
does not currently offer access to treatment services for Type 2 diabetes.
Motions for summary judgment are due April 16, 2026